March 19, 2018 04:12 PM EDT
Pharma

Don­ald Trump promis­es (again) to slash drug prices sub­stan­tial­ly; 'and it’s go­ing to be beau­ti­ful’

John Carroll

Editor & Founder

Near the be­gin­ning of Pres­i­dent Don­ald Trump’s ad­min­is­tra­tion, the chief ex­ec­u­tive of the coun­try made waves in bio­phar­ma with his re­peat­ed in­sis­tence that he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times